Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells

Stem Cells

Volumn 26, Issue 6, 2008, Pages 1598-1608

  Rider, David A ^a   Dombrowski, Christian ^a   Sawyer, Amber A ^a   Ng, Grace H B ^a   Leong, David ^b   Hutmacher, Dietmar W ^b   Nurcombe, Victor ^a,b   Cool, Simon M ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Adipogenesis; Adult bone marrow stem cells; Chondrogenesis; Mesenchymal stem cell; Microenvironment; Multipotential differentiation; Osteoblast

Indexed keywords

BIOCHEMICAL MARKER; CD146 ANTIGEN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FRIZZLED 1 PROTEIN; FRIZZLED PROTEIN; HLA ANTIGEN; PROTEIN FRAT1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WNT PROTEIN; DNA;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ARTICLE; AUTOCRINE EFFECT; BONE DEVELOPMENT; BONE MARROW CELL; CARTILAGE CELL; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PHENOTYPE; CELL DIFFERENTIATION; CLONOGENIC ASSAY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ADULT; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; COLONY-FORMING UNITS ASSAY; DNA; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PLURIPOTENT STEM CELLS; POLYMERASE CHAIN REACTION;

EID: 48249095121     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0480     Document Type: Article

References (45)

1. Friedenstein AJ, Piatetzky S II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966;16:381-390.
2. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211-228.
3. Gimble J, Guilak F. Adipose-derived adult stem cells: Isolation, characterization, and differentiation potential. Cytotherapy 2003;5:362-369.
4. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
5. Wagner W, Wein F, Seckinger A et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005;33:1402-1416.
6. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109:235-242.
7. Goodwin HS, Bicknese AR, Chien SN et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: Expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 2001;7:581-588.
8. Kern S, Eichler H, Stoeve J et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. STEM CELLS 2006;24:1294-1301.
9. Sakaguchi Y, Sekiya I, Yagishita K et al. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-2529.
10. Jiang Y, Vaessen B, Lenvik T et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002;30:896-904.
11. Horwitz EM, Gordon PL, Koo WK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002;99:8932-8937.
12. Chamberlain JR, Schwarze U, Wang PR et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 2004;303:1198-1201.
13. Arinzeh TL, Peter SJ, Archambault MP et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003;85-A:1927-1935.
14. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
15. Johnstone B, Hering TM, Caplan AI et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998;238:265-272.
16. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166.
17. Nishida S, Endo N, Yamagiwa H et al. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab 1999;17:171-177.
18. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001;82:583-590.
19. Stenderup K, Justesen J, Clausen C et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-926.
20. Liu TM, Martina M, Hutmacher DW et al. Identification of common pathways mediating differentiation of bone marrow- and adipose tissuederived human mesenchymal stem cells into three mesenchymal lineages. STEM CELLS 2007;25:750-760.
21. Huang JI, Kazmi N, Durbhakula MM et al. Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient-matched comparison. J Orthop Res 2005;23:1383-1389.
22. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage 2005;13:845-853.
23. Lee RH, Kim B, Choi I et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-324.
24. Gennari L, Merlotti D, De Paola V et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: A HuGE review. Am J Epidemiol 2005;161:307-320.
25. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: An inflammatory tale. J Clin Invest 2006;116:1186-1194.
26. Ling L, Murali S, Dombrowski C et al. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J Cell Physiol 2006;209:811-825.
27. Song SJ, Cool SM, Nurcombe V. Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2. J Cell Biochem 2007;100:402-411.
28. Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adiposederived stem cells. STEM CELLS 2006;24:2412-2419.
29. Helledie T, Jorgensen C, Antonius M et al. Role of adipocyte lipid-binding protein (ALBP) and acyl-coA binding protein (ACBP) in PPAR-mediated transactivation. Mol Cell Biochem 2002;239:157-164.
30. Parsch D, Fellenberg J, Brummendorf TH et al. Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med 2004;82:49-55.
31. Justesen J, Stenderup K, Eriksen EF et al. Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 2002;71:36-44.
32. Roura S, Farre J, Soler-Botija C et al. Effect of aging on the pluripotential capacity of human CD105- mesenchymal stem cells. Eur J Heart Fail 2006;8:555-563.
33. Fehrer C, Lepperdinger G. Mesenchymal stem cell aging. Exp Gerontol 2005;40:926-930.
34. Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev 2006;5:91-116.
35. De Ugarte DA, Alfonso Z, Zuk PA et al. Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 2003;89:267-270.
36. Afizah H, Yang Z, Hui JH et al. A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adiposederived stem cells (ADSCs) taken from the same donors. Tissue Eng 2007;13:659-666.
37. Gronthos S, Zannettino AC, Hay SJ et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-1835.
38. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48.
39. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-1441.
40. McIntosh K, Zvonic S, Garrett S et al. The immunogenicity of human adipose-derived cells: Temporal changes in vitro. STEM CELLS 2006;24:1246-1253.
41. Toh WS, Yang Z, Liu H et al. Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. STEM CELLS 2007;25:950-960.
42. Bianchi G, Banfi A, Mastrogiacomo M et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003;287:98-105.
43. Tsutsumi S, Shimazu A, Miyazaki K et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001;288:413-419.
44. Sotiropoulou PA, Perez SA, Salagianni M et al. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. STEM CELLS 2006;24:462-471.
45. Guillot PV, Gotherstrom C, Chan J et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. STEM CELLS 2007;25:646-654.